The monthly mortgage bill does not care that the paychecks stopped, and a savings account earning next to nothing will not close that gap for long. Four ETFs, stacked the right way,…
Covered call ETFs promise income, but most investors misunderstand what actually drives their payouts and when the strategy quietly works against them. Three funds from NEOS Investments reveal how the mechanics play…
The One Big Beautiful Bill quietly introduced a $12,000 senior deduction that certain income sources can erase before retirees even realize it, and the monthly paycheck many rely on is one of…
That monthly check from your high-yield S&P 500 ETF looks like income, but regulators classify certain payouts very differently from dividends, and the distinction carries serious consequences for your tax bill and…
A record pile of cash sits in money market funds feeling perfectly safe, but a quiet convergence happening right now is turning that safety into something far more costly than most investors…
JEPI pays monthly, keeps volatility low, and manages $46 billion in investor trust. So why are smaller, lesser-known funds quietly compounding circles around it this year, and what does that gap actually…
Both JEPI and SPYI pay monthly income from S&P 500 covered calls, but the IRS treats their distributions very differently, and for high-bracket investors in a taxable account, that distinction can quietly…
Goldman Sachs just wrote a $2.25 billion check for the firm behind a beloved 14% income ETF, and the reason they paid that price says something uncomfortable about who that yield actually…
NEOS built its reputation on a flagship S&P 500 income ETF that clears 12% annually, but a pair of younger siblings run the same playbook at a noticeably different intensity, and the…
SPYI publishes two yield figures that look like they belong to completely different funds, and both are calculated correctly. Understanding why reveals something uncomfortable about how income-focused investors are actually reading their…
With volatility near a 12-month low, the premium that SPYI, JEPQ, and GPIQ convert into monthly cash has shrunk, and a $500,000 stake in the wrong fund now exposes a flaw most…
Medicare's 2026 drug cap sounds like protection until you realize you fund the first $2,100 yourself, and a bad refill month can drain that before summer. Three ETFs can quietly cover that…
SPYI's eye-catching monthly payouts hide a tax mechanic that quietly rewrites your cost basis every single distribution, and investors who spend the checks without tracking the paperwork could face a surprise reckoning…
Real estate is finally roaring back, but the same fund that carried investors through years of rate pain now looks like the wrong tool for collecting that recovery as cash. A newer…
Selling shares to fund retirement works fine until a market crash forces you to liquidate at the worst possible moment. Three covered-call ETFs offer a completely different income strategy, but picking the…
